| abstract |
The present invention relates to compounds of formula (I) which inhibit the farnesylation of gene products through the inhibition of the enzyme farnesyl-protein transferase (FPTase). The present invention also relates to methods of preparing the compounds, pharmaceutical compositions and methods of treating diseases, particularly cancer, mediated through farnesylation.n n n Formula I |